Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Lactobacillus reuteri

EU orphan designation number: EU/3/15/1436   
Active ingredient: Lactobacillus reuteri
Indication: Prevention of necrotising enterocolitis
Sponsor: Infant Bacterial Therapeutics AB
Bryggargatan 10, 111 21 Stockholm, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/02/2015 Orphan designation EMA/OD/237/14 (2015)936 of 12/02/2015
31/03/2016 Change of name and/or address of sponsor EMA/OD/237/14